The centers perform a combined 60,000 cataract procedures annually and will use Dexycu in their surgical protocols for treating ocular inflammation. EyePoint President and CEO Nancy Lurker said the company will work with Vision Center Network to broaden the drug’s U.S. adoption rate and help treat inflammation in patients.
More articles on surgery centers:
5 ways ASCs can manage orthopedic costs
US inching closer to financial crisis, CBO estimates say
Anthem concentrating on risk-based arrangements, appropriate care settings in 2020
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
